Walmart to Replace AstraZeneca in Nasdaq-100 Index
Nasdaq has announced that Walmart will replace AstraZeneca in the Nasdaq-100 Index, effective January 20, 2026. This change will trigger mechanical trading flows as index-tracking funds and ETFs rebalance their portfolios.
Insights:
Nasdaq has announced a significant change to its Nasdaq-100 Index , with Walmart Inc. set to replace AstraZeneca PLC starting January 20, 2026. This strategic shift, unveiled on January 9, 2026, will have direct implications for the trading dynamics of both companies, as index-tracking funds and ETFs, such as the Invesco QQQ Trust , adjust their holdings to reflect the new index composition.
